We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 1,065

SEC settles with stock promoters in medical marijuana stock manipulation scheme
  • Katten Muchin Rosenman LLP
  • USA
  • July 17 2015

On July 9, the Securities and Exchange Commission settled with two stock promoters accused of reaping $2.5 million in illicit profits by manipulating

State AGs in the news
  • Dickstein Shapiro LLP
  • USA
  • May 15 2014

Bernard Nash and Milton A. Marquis Hot News Blog Post: Think You're Not a Holder of Unclaimed Property? Think Again! All 50 states have unclaimed

Online health care, consumer data, cybersecurity risks, accounting fraud, patents Expect Focus Vol. II, Spring 2015
  • Carlton Fields Jorden Burt
  • Global, USA
  • June 17 2015

Large-scale data breaches have become increasingly common, bringing with them not only bad press and loss of customer goodwill

White collar roundup - April 2014
  • Day Pitney LLP
  • USA
  • April 1 2014

In United States v. Gupta the U.S. Court of Appeals for the Second Circuit affirmed the conviction of Rajat Gupta for his participation in the Raj

SEC files another fraud action tied to the municipal bond market
  • Dorsey & Whitney LLP
  • USA
  • September 15 2013

The SEC filed another settled financial fraud action tied to the municipal bond market which is clearly an area of increasing focus. This proceeding

2013 year-end Foreign Corrupt Practices Act update
  • Baker & Hostetler LLP
  • Libya, USA
  • February 10 2014

The third and fourth quarters of 2013 proved to be eventful and poten- tially prophetic as to the course the Foreign Corrupt Practices Act ("FCPA"

Last man standing
  • Cooley LLP
  • USA
  • December 27 2013

The Gentiva securities class action is based on allegations that the company violated Medicare rules and artificially inflated the Medicare payments

Third Circuit vacates dismissal of Celebrex securities fraud class action
  • Locke Lord LLP
  • USA
  • February 17 2009

The United States Court of Appeals for the Third Circuit (“Third Circuit”) recently vacated the dismissal of a securities fraud class action alleging that a pharmaceutical company, Pharmacia, Inc., made materially false statements about a clinical study of a popular anti-inflammatory medication

Denial of leave to amend securities complaint affirmed on basis of futility
  • Katten Muchin Rosenman LLP
  • USA
  • March 28 2008

The Court of Appeals for the Eighth Circuit affirmed a decision dismissing Plaintiff’s class action securities fraud complaint and denying Plaintiff leave to amend

Genzyme First Circuit decision
  • Baker & Hostetler LLP
  • USA
  • June 13 2014

In a huge victory for Massachusetts-based biologics manufacturer Genzyme Corporation, the First Circuit Court of Appeals on June 5, 2014 affirmed the